Enveric Biosciences, Inc. (ENVB)
About Enveric Biosciences, Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2019
- $39.9M
- Net income
- -$8.8M
- Total assets
- $5.1M
- Market cap
- $6.6M
- Operating margin
- 8277781.1%
- Net margin
- 8275459.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- -$106
- Operating expenses
- $8.8M
- Operating income
- -$8.8M
- Net income
- -$8.8M
- EPS (basic)
- $-36.24
- EPS (diluted)
- $-36.24
Balance sheet
- Total assets
- $5.1M
- Current assets
- $4.9M
- Total liabilities
- $918.4K
- Current liabilities
- $918.4K
- Shareholders’ equity
- $4.2M
Cash flow
- Operating cash flow
- -$8.1M
- Investing cash flow
- -$2.4M
- Financing cash flow
- $10.6M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $6.6M
- EPS (diluted)
- $-36.24
- Shares outstanding
- 5.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 24, 1995
Enveric Biosciences, Inc. (ENVB) Stock Price
- Reported a net loss of $8.8M in FY2019.
- Trading 93% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Enveric Biosciences, Inc..
Write a review
News about Enveric Biosciences, Inc.
News & sentiment via Polygon.io
Enveric Biosciences, Inc.: frequently asked questions
Is Enveric Biosciences, Inc. an American company?
Enveric Biosciences, Inc. is a US-based company headquartered in Cambridge, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Enveric Biosciences, Inc. headquartered?
Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts, United States.
Is Enveric Biosciences, Inc. publicly traded?
Yes — Enveric Biosciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol ENVB on the NASDAQ.
What does Enveric Biosciences, Inc. do?
Enveric Biosciences, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
